Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

PTIE

Pain Therapeutics (PTIE)

Pain Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTIE
DateHeureSourceTitreSymboleSociété
29/03/201913h25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
29/03/201911h09Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
27/03/201920h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
27/03/201913h30GlobeNewswire Inc.Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.NASDAQ:PTIEPain Therapeutics, Inc. (MM)
25/03/201913h30GlobeNewswire Inc.Pain Therapeutics Reports 2018 Financial Results and Corporate UpdateNASDAQ:PTIEPain Therapeutics, Inc. (MM)
04/03/201920h56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
14/02/201921h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
05/02/201914h00GlobeNewswire Inc.Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXYNASDAQ:PTIEPain Therapeutics, Inc. (MM)
31/01/201912h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
17/01/201915h00GlobeNewswire Inc.Pain Therapeutics Announces Academic Collaboration with The University of Texas at AustinNASDAQ:PTIEPain Therapeutics, Inc. (MM)
16/01/201915h00GlobeNewswire Inc.Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of HealthNASDAQ:PTIEPain Therapeutics, Inc. (MM)
07/01/201914h30GlobeNewswire Inc.Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXYNASDAQ:PTIEPain Therapeutics, Inc. (MM)
19/12/201800h00GlobeNewswire Inc.Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1NASDAQ:PTIEPain Therapeutics, Inc. (MM)
18/12/201823h29Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
06/12/201813h30GlobeNewswire Inc.Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s DiseaseNASDAQ:PTIEPain Therapeutics, Inc. (MM)
12/11/201813h30GlobeNewswire Inc.Pain Therapeutics Appeals FDA Decision on REMOXYNASDAQ:PTIEPain Therapeutics, Inc. (MM)
01/11/201821h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
31/10/201821h04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
30/10/201821h44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
29/10/201821h05GlobeNewswire Inc.Pain Therapeutics Reports Third Quarter 2018 Financial ResultsNASDAQ:PTIEPain Therapeutics, Inc. (MM)
23/10/201813h30GlobeNewswire Inc.Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial ResultsNASDAQ:PTIEPain Therapeutics, Inc. (MM)
11/10/201813h30GlobeNewswire Inc.Pain Therapeutics Announces Appointment of Chief Financial OfficerNASDAQ:PTIEPain Therapeutics, Inc. (MM)
04/10/201813h30GlobeNewswire Inc.Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s DiseaseNASDAQ:PTIEPain Therapeutics, Inc. (MM)
03/10/201801h48GlobeNewswire Inc.Pain Therapeutics Announces Investor Call to Provide Strategic UpdateNASDAQ:PTIEPain Therapeutics, Inc. (MM)
30/08/201818h16Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
17/08/201823h15GlobeNewswire Inc.Pain Therapeutics Announces Closing of $11.3 Million Registered Direct OfferingNASDAQ:PTIEPain Therapeutics, Inc. (MM)
17/08/201818h46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
16/08/201813h00GlobeNewswire Inc.Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-MarketNASDAQ:PTIEPain Therapeutics, Inc. (MM)
16/08/201812h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PTIEPain Therapeutics, Inc. (MM)
15/08/201814h00GlobeNewswire Inc.Pain Therapeutics Awarded $3.2 Million NIH Grant to Study Alzheimer’s DiseaseNASDAQ:PTIEPain Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:PTIE